Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

Josep Corominas; Victor Sapena; Marco Sanduzzi-Zamparelli; Cristina Millán; Esther Samper; Neus Llarch; Gemma Iserte; Ferràn Torres; Leonardo G. Da Fonseca; Sergio Muñoz-Martínez; Alejandro Forner; Jordi Bruix; Loreto Boix; María Reig

doi:10.3390/cancers13030426

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

Josep Corominas, Victor Sapena, Marco Sanduzzi-Zamparelli, Cristina Millán, Esther Samper, Neus Llarch, Gemma Iserte, Ferràn Torres, Leonardo G. Da Fonseca, Sergio Muñoz-Martínez, Alejandro Forner, Jordi Bruix, Loreto Boix, María Reig

Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine and Public Health

Research output: Contribution to journal › Article › Research › peer-review

Original language	Undefined/Unknown
Journal	Cancers
DOIs	https://doi.org/10.3390/cancers13030426
Publication status	Published - 23 Jan 2021

Access to Document

10.3390/cancers13030426

https://doi.org/10.3390/cancers13030426

Cite this

Corominas, J., Sapena, V., Sanduzzi-Zamparelli, M., Millán, C., Samper, E., Llarch, N., Iserte, G., Torres, F., Fonseca, L. G. D., Muñoz-Martínez, S., Forner, A., Bruix, J., Boix, L., & Reig, M. (2021). Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma. Cancers. https://doi.org/10.3390/cancers13030426

Corominas, Josep ; Sapena, Victor ; Sanduzzi-Zamparelli, Marco ; Millán, Cristina ; Samper, Esther ; Llarch, Neus ; Iserte, Gemma ; Torres, Ferràn ; Fonseca, Leonardo G. Da ; Muñoz-Martínez, Sergio ; Forner, Alejandro ; Bruix, Jordi ; Boix, Loreto ; Reig, María. / Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma. In: Cancers. 2021.

@article{ab9ba0ee92834176b14e6ca35cccf33e,

title = "Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma",

author = "Josep Corominas and Victor Sapena and Marco Sanduzzi-Zamparelli and Cristina Mill{\'a}n and Esther Samper and Neus Llarch and Gemma Iserte and Ferr{\`a}n Torres and Fonseca, {Leonardo G. Da} and Sergio Mu{\~n}oz-Mart{\'i}nez and Alejandro Forner and Jordi Bruix and Loreto Boix and Mar{\'i}a Reig",

year = "2021",

month = jan,

day = "23",

doi = "10.3390/cancers13030426",

language = "Indefinido/desconocido",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

}

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma. / Corominas, Josep; Sapena, Victor; Sanduzzi-Zamparelli, Marco; Millán, Cristina; Samper, Esther; Llarch, Neus; Iserte, Gemma; Torres, Ferràn; Fonseca, Leonardo G. Da; Muñoz-Martínez, Sergio; Forner, Alejandro; Bruix, Jordi; Boix, Loreto; Reig, María.

In: Cancers, 23.01.2021.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

AU - Corominas, Josep

AU - Sapena, Victor

AU - Sanduzzi-Zamparelli, Marco

AU - Millán, Cristina

AU - Samper, Esther

AU - Llarch, Neus

AU - Iserte, Gemma

AU - Torres, Ferràn

AU - Fonseca, Leonardo G. Da

AU - Muñoz-Martínez, Sergio

AU - Forner, Alejandro

AU - Bruix, Jordi

AU - Boix, Loreto

AU - Reig, María

PY - 2021/1/23

Y1 - 2021/1/23

UR - https://doi.org/10.3390/cancers13030426

U2 - 10.3390/cancers13030426

DO - 10.3390/cancers13030426

M3 - Artículo

C2 - 33498698

JO - Cancers

JF - Cancers

SN - 2072-6694

ER -